Oral rehydration salts with rice powder
- Drugs List
- Therapeutic Indications
- Dosage
- Administration
- Contraindications
- Precautions and Warnings
- Pregnancy and Lactation
- Side Effects
- Monograph
Presentation
Sugar free oral powder containing rice powder (pre-cooked) 6g, sodium citrate 580mg, sodium chloride 350mg, potassium chloride 300mg per sachet.
Drugs List
Therapeutic Indications
Uses
Correction of fluid and electrolyte loss.
Treatment of watery diarrhoea of various aetiologies.
Dosage
Adults
One sachet after every loose motion, maximum of 5 sachets per day for 3 to 4 days.
Children
Children aged over 1 year
One sachet after every loose motion, maximum of 5 sachets per day for 3 to 4 days.
Infants aged 3 months to 1 year
For loss of weight assessed at less than 10%, 150ml/kg to 200ml/kg per 24 hours. Half the volume should be given during the first 8 hours, and the other half during the next 16 hours.
If vomiting accompanies the diarrhoea, administer 5ml to 10ml every 5 minutes, gradually increasing the amount given until the infant can drink normally.
The following alternative dosing schedule may be suitable:
Children aged 12 to 18 years: 200ml to 400ml after every loose motion.
Children aged 1 to 12 years: 200ml after every loose motion.
Children aged 3 months to 1 year: 1 to 1.5 times the usual feed volume.
Children aged 1 month to 3 months (unlicensed): 1 to 1.5 times the usual feed volume.
Patients with Renal Impairment
Contraindicated in severe renal impairment.
Patients with Hepatic Impairment
Contraindicated in severe hepatic impairment.
Administration
For oral administration
Reconstitution
The contents of each sachet to be mixed with water before administration.
Pour contents of one sachet into a large glass of water (200ml). Mix well.
For infants, and if drinking water is not available, the water should be freshly boiled and cooled.
Once reconstituted, any solution should be used within one hour, or within 24 hours if stored in a refrigerator.
Contraindications
Phenylketonuria (contains aspartame)
Intestinal obstruction
Paralytic ileus
Severe dehydration requiring parenteral fluid therapy
Severe renal impairment
Severe hepatic impairment
Neonates
Precautions and Warnings
Use with caution in conditions which may cause electrolyte imbalance.
Children under 1 year of age - use under medical advice only. Not licensed in children under 3 months.
Pregnancy - use only on the advice of a doctor.
Breastfeeding - use only on the advice of a doctor.
Advise patient to consult their doctor if symptoms persist for more than 36 hours.
Patients on sodium or potassium restricted diets should use oral rehydration salts only under medical supervision.
Pregnancy and Lactation
Pregnancy
Use with caution in pregnancy on medical advice only.
Lactation
Use with caution while breastfeeding on medical advice only.
Effects on Ability to Drive and Operate Machinery
None known.
Counselling
Advise patient to consult their doctor if symptoms persist for more than 36 hours
Side Effects
None known.
Overdosage
It is strongly recommended that the UK National Poisons Information Service be consulted on cases of suspected or actual overdose where there is doubt over the degree of risk or about appropriate management.
The following number will direct the caller to the relevant local centre (0844) 892 0111
Information may be obtained if you have access to ToxBase the primary clinical toxicology database of the National Poisons Information Service. This is available via password on the internet ( www.toxbase.org ) or if this is unavailable at the backup site ( www.toxbasebackup.org ).
Shelf Life and Storage
Store in a dry place under 25 degrees C.
Further Information
Last Full Review Date: May 2012
Reference Sources
Summary of Product Characteristics: Dioralyte Relief Blackcurrant. Sanofi Aventis. Revised April 2011.
Summary of Product Characteristics: Dioralyte Relief Raspberry and Blackcurrant. Sanofi Aventis. Revised February 2020.
NICE Evidence Services Available at: www.nice.org.uk Last accessed: 14 September 2017
Medscape UK | Univadis prescription drug monographs & interactions are based on FDB Multilex Content
FDB Disclaimer : FDB Multilex is intended for the use of healthcare professionals and is provided on the basis that the healthcare professionals will retain FULL and SOLE responsibility for deciding what treatment to prescribe or dispense for any particular patient or circumstance.